Market research
688298.SHG Zhejiang Orient Gene Biotech Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- 377.14
- Dividend yield
- Not available
- Beta
- 0.83
Community
Investor discussion
1 comment
Sign in to join the 688298.SHG discussion.
5 years, 5 months ago
Zhejiang Orient Gene Biotech Co., Ltd is currently in a long term uptrend where the price is trading 31.7% above its 200 day moving average.
From a valuation standpoint, the stock is 23.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 11.9.
Based on the above factors, Zhejiang Orient Gene Biotech Co., Ltd gets an overall score of 1/5.